Why we exist
Why we exist
We exist to bring Oxford science to the world
Transforming cutting-edge research into companies to solve the world’s greatest challenges and deliver strong returns for investors.
What we do
What we do
We’re an independent investment company and venture builder
Powered by a unique partnership with the University of Oxford, we work with leading scientific minds and global investors to build transformational ventures.
Johannes Feldmann and Vaysh Kewada, Salience
How we work
How we work
We find. We fund. We build.
Our team works hand in hand with world-class researchers and entrepreneurs. We find bold ideas, fund them with patient capital, and build companies ready to change the world.
Dr Chris Ballance, Oxford Ionics
Dr Chris Ballance, Oxford Ionics
Our impact
Our impact
50+ flagship companies
300+ co-investors
£1.3bn net asset value
Ten years in, we’ve built a proven venture-building engine and a diverse pipeline with multi-billion-pound potential.
Who we are
Who we are
We’re a team of investors, entrepreneurs, and venture builders
With more than 60 people based in the heart of Oxford, we are united by one goal: turning world-class science into world-changing, billion-pound companies.
Stories
Oxford Ionics: Reimagining quantum computing
From academic breakthrough to $1bn acquisition – a story of deep science, patient capital, and bold ambition.
Alethio: Innovative medicines for chronic blood cancer
Alethio Therapeutics is redefining how we treat incurable blood cancers – by targeting the cells that drive them.
